Key facts
- Chemify’s last known valuation is $145.1M (Oct 2025).
- It has raised $124.2M; the latest was Grant ($3.2M) in Dec 2025.
- Notable investors include Innovate UK, Insight Partners (New York), Founders Fund, 8VC, DCVC — 27 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Chemify
- ·The full record, as it builds
Funding rounds
No funding rounds for Chemify are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chemify
Developer of a chemical digitization platform intended to run chemical code for drug and materials discovery and chemical synthesis. The company's software involves a chemical programming language, natural language recognition for the translation of synthetic procedures, and a comprehensive ontology that allows for the straightforward creation of processes with insight into reaction conditions and flagging potential problems, enabling scientists to have detailed real-time reaction telemetry.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2019
- Employees
- 154
- Website
- chemify.io/
- Ownership
- Privately Held (backing)
Chemify doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chemify shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chemify in its N-PORT filings yet. We sweep new filings monthly.